Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-24-000199

Director sold 5,425 shares at $28.54 ($154,830)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Douglas J. Director 2024-12-02 Sale 10b5-1 −5,425 $28.54 $154,830 119,585 D
Open-market sales · 5,425 sh · avg $28.54 · $154,830
Loading xslF345X05/wk-form4_1733347209.xml…